Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 58.61
(-4.17%)
INR 58.61
(-4.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 479.74 Million INR | 2.55% |
| 2022 | 467.82 Million INR | 16.57% |
| 2021 | 401.33 Million INR | 59.4% |
| 2020 | 251.77 Million INR | -32.94% |
| 2019 | 375.43 Million INR | 20.99% |
| 2018 | 310.3 Million INR | 6.95% |
| 2017 | 290.14 Million INR | 14.74% |
| 2016 | 252.87 Million INR | 1.18% |
| 2015 | 249.93 Million INR | -5.62% |
| 2014 | 264.81 Million INR | -8.2% |
| 2013 | 288.46 Million INR | -63.49% |
| 2012 | 790.15 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | 128.88 Million INR | 8.26% |
| 2023 FY | 479.74 Million INR | 2.55% |
| 2023 Q4 | 130.2 Million INR | 8.23% |
| 2023 Q3 | 120.3 Million INR | 12.25% |
| 2023 Q2 | 107.17 Million INR | -16.85% |
| 2022 Q3 | 125.75 Million INR | 33.59% |
| 2022 Q1 | 93.24 Million INR | -13.23% |
| 2022 Q4 | 119.04 Million INR | -5.33% |
| 2022 Q2 | 94.13 Million INR | 0.95% |
| 2022 FY | 467.82 Million INR | 16.57% |
| 2021 Q3 | 101.26 Million INR | 1.91% |
| 2021 Q1 | 59.15 Million INR | -16.51% |
| 2021 FY | 401.33 Million INR | 59.4% |
| 2021 Q4 | 107.46 Million INR | 6.12% |
| 2021 Q2 | 99.36 Million INR | 67.99% |
| 2020 Q3 | 71.98 Million INR | 44.53% |
| 2020 FY | 251.77 Million INR | -32.94% |
| 2020 Q2 | 49.8 Million INR | -46.7% |
| 2020 Q4 | 70.84 Million INR | -1.58% |
| 2020 Q1 | 93.44 Million INR | -7.61% |
| 2019 Q2 | 69.36 Million INR | -13.53% |
| 2019 FY | 375.43 Million INR | 20.99% |
| 2019 Q1 | 80.21 Million INR | -3.41% |
| 2019 Q3 | 111.48 Million INR | 60.71% |
| 2019 Q4 | 101.14 Million INR | -9.28% |
| 2018 Q4 | 83.05 Million INR | 4.29% |
| 2018 FY | 310.3 Million INR | 6.95% |
| 2018 Q3 | 79.63 Million INR | 18.16% |
| 2018 Q2 | 67.39 Million INR | -22.23% |
| 2018 Q1 | 86.66 Million INR | 12.26% |
| 2017 Q1 | 53.94 Million INR | -11.71% |
| 2017 Q3 | 81.94 Million INR | 84.84% |
| 2017 Q4 | 77.19 Million INR | -5.79% |
| 2017 Q2 | 44.33 Million INR | -17.81% |
| 2017 FY | 290.14 Million INR | 14.74% |
| 2016 FY | 252.87 Million INR | 1.18% |
| 2016 Q3 | 86.42 Million INR | 68.06% |
| 2016 Q4 | 61.09 Million INR | -29.31% |
| 2016 Q2 | 51.42 Million INR | -24.16% |
| 2016 Q1 | 67.8 Million INR | 0.45% |
| 2015 Q4 | 67.5 Million INR | 12.4% |
| 2015 FY | 249.93 Million INR | -5.62% |
| 2015 Q1 | 74.95 Million INR | 21.19% |
| 2015 Q2 | 54.56 Million INR | -27.2% |
| 2015 Q3 | 60.06 Million INR | 10.07% |
| 2014 Q1 | 112.75 Million INR | 81.09% |
| 2014 FY | 264.81 Million INR | -8.2% |
| 2014 Q4 | 61.85 Million INR | -11.48% |
| 2014 Q3 | 69.87 Million INR | 20.19% |
| 2014 Q2 | 58.13 Million INR | -48.44% |
| 2013 Q1 | 57.88 Million INR | -44.3% |
| 2013 FY | 288.46 Million INR | -63.49% |
| 2013 Q3 | 67.69 Million INR | 47.93% |
| 2013 Q2 | 45.75 Million INR | -20.96% |
| 2013 Q4 | 62.26 Million INR | -8.02% |
| 2012 Q2 | 610.12 Million INR | 897.32% |
| 2012 Q4 | 103.92 Million INR | -10.44% |
| 2012 FY | 790.15 Million INR | 0.0% |
| 2012 Q1 | 61.17 Million INR | -76.91% |
| 2012 Q3 | 116.03 Million INR | -80.98% |
| 2011 Q3 | 346.82 Million INR | 0.0% |
| 2011 Q4 | 264.89 Million INR | -23.62% |
| 2010 Q1 | 60.16 Million INR | 0.0% |
| 2009 Q1 | 43.1 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.46 Billion INR | 67.165% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | 44.106% |
| Beryl Drugs Limited | 271.24 Million INR | -76.867% |
| Cian Healthcare Limited | 616.95 Million INR | 22.24% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -2509.874% |
| Deccan Health Care Limited | 597.28 Million INR | 19.679% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -32.252% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 76.26% |
| Concord Drugs Limited | 449.24 Million INR | -6.79% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 71.75% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -4473.577% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -215.881% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 66.207% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 54.256% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 84.382% |
| Makers Laboratories Limited | 1.03 Billion INR | 53.765% |
| Medi-Caps Limited | 265.63 Million INR | -80.604% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.147% |
| Panchsheel Organics Limited | 1.05 Billion INR | 54.405% |
| Parmax Pharma Limited | 154.24 Million INR | -211.032% |
| Parnax Lab Limited | 1.88 Billion INR | 74.578% |
| Patidar Buildcon Limited | 2.3 Million INR | -20686.265% |
| Phaarmasia Limited | 305.93 Million INR | -56.814% |
| PRAVEG LIMITED | 915.96 Million INR | 47.624% |
| Sunil Healthcare Limited | 901.91 Million INR | 46.808% |
| Syschem (India) Limited | 2.33 Billion INR | 79.457% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 10.64% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 96.462% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -42811.181% |
| Smruthi Organics Limited | 1.27 Billion INR | 62.415% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -75.752% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 89.65% |
| Trident Lifeline Limited | 446.28 Million INR | -7.498% |
| Transchem Limited | 4.09 Million INR | -11601.149% |
| Trinity League India Limited | 2.95 Million INR | -16162.61% |
| Tyche Industries Limited | 696.83 Million INR | 31.154% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 61.746% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -366.326% |
| Vivanza Biosciences Limited | 278.89 Million INR | -72.019% |
| Zenith Healthcare Limited | 144.71 Million INR | -231.507% |
| Zenlabs Ethica Limited | 585.63 Million INR | 18.08% |
| Mercury Laboratories Limited | 755.59 Million INR | 36.507% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -19.868% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -29.597% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -7.545% |
| Roopa Industries Limited | 715.53 Million INR | 32.953% |
| PANJON LTD. | 125.52 Million INR | -282.205% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -217.459% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 92.585% |
| Crestchem Limited | 212.56 Million INR | -125.697% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -8540.976% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 28.695% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 86.22% |
| Trimurthi Limited | 42.23 Million INR | -1035.818% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 35.667% |
| Norris Medicines Limited | 56.35 Million INR | -751.277% |
| Veerhealth Care Limited | 142.13 Million INR | -237.531% |
| Lactose (India) Limited | 1.13 Billion INR | 57.876% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -21.02% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 72.48% |
| Gennex Laboratories Limited | 867.14 Million INR | 44.675% |
| Denis Chem Lab Limited | 1.67 Billion INR | 71.413% |
| Colinz Laboratories Limited | 70.29 Million INR | -582.467% |
| Godavari Drugs Limited | 1.56 Billion INR | 69.387% |
| Zenotech Laboratories Limited | 368.08 Million INR | -30.335% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 61.893% |
| Bharat Parenterals Limited | 2.59 Billion INR | 81.506% |
| Coral Laboratories Limited | 836.6 Million INR | 42.655% |
| Evoq Remedies Limited | 63.09 Million INR | -660.417% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 53.12% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 69.132% |
| Auro Laboratories Limited | 526.99 Million INR | 8.966% |